The 5 analysts offering 12-month price forecasts for Syros Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 60.00 and a low estimate of 15.00. The median estimate represents a +256.35% increase from the last price of 4.49.
The current consensus among 6 polled investment analysts is to Buy stock in Syros Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.23
Reporting Date Mar 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.